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Abstract
Background: Although the embryonic expression pattern of ADP ribosylation factor-like 6 interacting protein 1 (Arl6ip1) has
been reported, its function in neural crest development is unclear.
Methods/Principal Findings: We found that knockdown of Arl6ip1 caused defective embryonic neural crest derivatives that
were particularly severe in craniofacial cartilages. Expressions of the ectodermal patterning factors msxb, dlx3b, and pax3
were normal, but the expressions of the neural crest specifier genes foxd3, snai1b, and sox10 were greatly reduced. These
findings suggest that arl6ip1 is essential for specification of neural crest derivatives, but not neural crest induction.
Furthermore, we revealed that the streams of crestin- and sox10-expressing neural crest cells, which migrate ventrally from
neural tube into trunk, were disrupted in arl6ip1 morphants. This migration defect was not only in the trunk neural crest, but
also in the enteric tract where the vagal-derived neural crest cells failed to populate the enteric nervous system. We found
that this migration defect was induced by dampened Shh signaling, which may have resulted from defective cilia. These
data further suggested that arl6ip1 is required for neural crest migration. Finally, by double-staining of TUNEL and crestin,
we confirmed that the loss of neural crest cells could not be attributed to apoptosis.
Conclusions/Significance: Therefore, we concluded that arl6ip1 is required for neural crest migration and sublineage
specification.
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Introduction
The neural crest (NC) contains pluripotent cells which are
derived from the border of the neural and epidermal ectoderm
and migrate through specific migration pathways in vertebrate
embryos. NC cells contribute to the development of such cell types
as facial cartilage and bones, neurons, pigment cells and glia of the
peripheral nervous system, melanocytes of the skin, and smooth
muscle of the heart. At the end of gastrulation, the NC arises at the
border, which is also known as the neural fold, and flanks the
neural plate bilaterally. During neurulation, the neural plate bends
and folds into the neural tube and brings the neural folds together
at the dorsal midline. During the folding process, NC precursors
are contained within the neural fold. Subsequently, these cells
undergo an epithelial-mesenchymal transition, which allows them
to delaminate from the neuroepithelium and migrate away from
the neural tube to various sites of the embryo [1,2]. NC cells from
the midbrain and hindbrain regions migrate throughout the head
and contribute to most of the cartilage and bones of the head, as
well as neurons of cranial ganglia. The caudal hindbrain zone of
the NC, also known as the vagal crest, contributes to the heart and
the enteric nervous system. The trunk NC cells give rise to sensory
and sympathetic ganglia [3].
Because the NC possesses the ability to generate multiple cell
lineages, any abnormal development of the NC has serious
repercussions for many different organs. These pathologies, known
as neurocristopathies, include conditions such as Waardenburg–
Shah syndrome (hypopigmentation and aganglionic megacolon),
frontonasal dysplasia (multiple craniofacial defects), and DiGeorge
syndrome (craniofacial and heart defects). Therefore, discovering
the mechanisms of NC formation and diversification represents an
important step in understanding the basis of these pathologies [4].
NC development describes the progression of a NC cell over
time from the initial commitment of the cell to its specific fate to its
fully differentiated function. In this paper, we are particularly
concerned with NC induction and sublineage specification. NC
induction refers to the induction of ectoderm cells to the NC
lineage and the ability to segregate and migrate away from the
neuroepithelium. In fact, studies of mouse, frog, chick and
zebrafish NC development have implicated multiple signaling
molecules, including BMPs, FGFs, and Wnt proteins, as well as
retinoic acid and Notch, in this process [5,6,7,8,9,10,11,12,13,14].
In addition, the pre-migratory NC cells are identifiable by the
expression of NC specifier genes, including slug, ap-2, foxd3, sox10
and pax3 [7,9,15,16,17,18,19,20]. However, it remains unclear
whether the genes encoding the molecular signals that initiate the
migration of NC cells through the embryo are the same as those
that determine their ultimate fate. Thus, the specification of NC at
the neural plate border and the processes involved in determining
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remain to be elucidated. Nonetheless, it is thought that the
downstream effector genes resulting from the interaction between
inductive signals and transcriptional regulators govern NC
development.
Following this reasoning, ADP-ribosylation factor-like 6 (Arl6),
which belongs to the small ADP ribosylation factor GTP-binding
proteins, is a major regulator in intracellular traffic, and Arl6ip1 is
an interacting protein of Arl6. In mouse, arl6ip1 is expressed in all
hematopoietic cell lineages and in the early myeloid progenitor
cells. Arl6ip1 protein is also dominantly localized in intracyto-
plasmic membranes, suggesting that arl6ip1 functions in protein
transport, membrane trafficking, or cell signaling during hemato-
poietic maturation [21]. Lui et al. (2003) [22] demonstrated that
ARMER, also named human Arl6ip1, is a novel ER integral
membrane protein which plays a possible role in cell survival by
protecting cells through inhibition of caspase-9 activity. Mutation
of Arl6 causes Bardet-Biedl syndrome (BBS), a multisystemic
disorder characterized by obesity, blindness, polydactyly, renal
abnormalities, cognitive impairment and Hirschprung disease
[23]. Interestingly, analysis of BBS morphants in zebrafish showed
that aberrant NC migration underlies the craniofacial and enteric
nervous system defects mirroring mammalian mutants [24],
suggesting that BBS-associated genes might be involved in NC
migration. Recently, Huang et al. (2009) [25] reported that arl6ip1
is a maternal gene and is expressed ubiquitously through 24 hours
post-fertilization (hpf). They also showed that knockdown of
arl6ip1 by injection of arl6ip1-specific antisense morpholino
oligonucleotides (MO; arl6ip1-MO1) resulted in displaying short-
ened mandibles with loss of pharyngeal arches and reduced
pigmentation, suggesting that the NC of arl6ip1-MO1-treated
embryos may be defective. By Western blot analysis, Huang et al.
(2009) [25] demonstrated that the protein level of Arl6ip1 is
greatly reduced in the arl6ip1-MO1-injected embryos, indicating
the specificity and reliability of arl6ip1-MO1 by loss-of-function
studies. Taken together, this evidence led us to hypothesize that
arl6ip1 may play an important role in NC development. Therefore,
we investigated the function of zebrafish arl6ip1 during embryo-
genesis by means of MO to knock down arl6ip1 mRNA
translation. Knockdown of Arl6ip1 activity resulted in reduction,
or even loss, of NC derivatives, including pharyngeal arches,
cranial and trunk ganglia, enteric neurons and pigment cells.
While the induction of NC remained unchanged, later specifica-
tion of sublineages was reduced in the arl6ip1-MO1-injected
embryos. This line of evidence further implicated that arl6ip1 plays
a role in the specification of NC derivatives. In addition, we also
proved that the down-regulation of the pre-migratory NC markers
foxd3, sox10, and snai1b could not be attributed to cell death.
Rather, it is suspected that a decreased level of these genes at early
somatic stage may cause major defects in the specification of NC
derivatives at later stages of embryonic development. Moreover,
we concluded that arl6ip1 may act parallel to, or downstream of,
pax3 and msxb, but upstream of foxd3, sox10 and snai1b. This
suggests that Arl6ip1 is not only required for specification of NC
derivatives, but migration, as well. Finally, we demonstrated that
shh signaling pathway may be disrupted by defective cilia, leading
to the perturbation of NC cell migration and left-right laterality.
Thus, the etiology underlying various neurocristopathies, as noted
above, including craniofacial dysmorphology and Hirschsprung’s
disease in BBS, could very likely arise from abnormalities in arl6ip1
expression and function, as these ultimately impact NC develop-
ment.
Results
Knockdown of arl6ip1 resulted in ectoderm-derived
defects of embryos
To investigate whether Arl6ip1 is required for early develop-
ment, we injected embryos with arl6ip1-MO1 which specifically
blocked the translation of arl6ip1 mRNA. Many morphological
defects were observed in the 4 ng arl6ip1-MO1-injected embryos,
compared to the control-MO-injected embryos. For example, at
24 hpf, the yolk extension and tail were foreshortened, pericardial
edema was present, lens and otic vesicles were absent or highly
reduced in size, and the head became smaller (Figs. 1A–C).
However, since apoptosis can be induced by MO-toxicity, p53-
MO was reported by Robu et al. (2007) as an excellent tool to
attenuate neural cell death, but with no effect on embryonic
morphology [26]. Therefore, we co-injected p53-MO to prevent
nonspecific defects caused by cell death. Compared to wild-type
embryos, both arl6ip1-MO1 and arl6ip1-MO1 combined with p53-
MO (arl6ip1-MO1/p53-MO) morphants showed reduced cell
numbers and mismigration of melanophores at 48 hpf (Figs. 1D–
F). At 96hpf, the iridophore pigment cells of arl6ip1-MO1
morphants, as well as arl6ip1-MO1/p53-MO-injected embryos,
were much reduced in comparison to wild-type embryos (Figs. 1G–
I, indicated by arrows).. The jaw morphology shown in wild-type
embryos at 96 hpf (indicated by double arrowhead in Fig. 1J) did
not form in arl6ip1-MO1-injected and arl6ip1-MO1/p53-MO-
injected embryos (Figs. 1K and L). The occurrence rates of
reduced iridophore cells and melanophores in the 4 ng arl6ip1-
MO1-injected embryos and in the 4 ng arl6ip1-MO1/6ng p53-
MO- injected embryos were 84.5% (93/110 ) and 79.5% (128/
161), respectively. The head size and trunk extension were also
recovered in arl6ip1-MO1/p53-MO-injected embryos at 24 hpf
(data not shown). Since the off-targeting effect was inhibited by
p53-MO, no NC derivatives could be rescued in the arl6ip1-MO1/
p53-MO-injected embryos. We also injected 8 ng of arl6ip1-MO2
into embryos, and the resulting defects phenocopied those of
arl6ip1-MO1-injected embryos (data not shown) [25]. These
findings suggested that knockdown of Arl6ip1 function causes
defects related to NC degeneration.
The occurrence rate of defects induced by injection of arl6ip1-
MO1 was dose-dependent (Table 1). We observed that higher
concentrations of injected arl6ip1-MO1 resulted in a correspond-
ingly higher rate of defects. However, when 4 ng arl6ip1-MO1
were co-injected with 150 and 200 pg of a wobble arl6ip1 mRNA
in embryos, the occurrence rates of mild defects were observed to
decrease from 48.4% to 32.1% and 17.6%, respectively, while the
occurrence rates of the wild-type-like phenotype increased from
16.1% to 56% and 77%, respectively (Table 1). Furthermore, co-
injection of 4 ng arl6ip1-MO1/p53-MO with 75 and 150 pg of a
wobble arl6ip1 mRNA in embryos decreased the occurrence rates
of mild defects from 74% to 34.5% and 17.5%, respectively, but
raised the occurrence rates of wild-type-like phenotype from
14.4% to 60.2% and 80.1%, respectively (Table 1, Fig. S1K). In
addition, we co-injected a wobble arl6ip1-gfp mRNA with arl6ip1-
MO1, and the Arl6ip1-GFP fusion protein was detected in
embryos (Figs. S1B and F), indicating that the injected arl6ip1-
MO1 failed to inhibit the translation of the introduced wobble
arl6ip1-gfp mRNA. Furthermore, either co-injection of arl6ip1-
MO1 or arl6ip1-MO1/p53-MO with a wobble arl6ip1 mRNA
rescued the defective phenotypes in embryos induced by arl6ip1-
MO1 (Figs. S1B and C, Table 1). To further confirm whether
phenotypes of these morphants were specifically induced by the
absence of Arl6ip1 function, we constructed a plasmid of pCS2-
Arl6ip1-GFP, in which the targeting sequence of arl6ip1-MO1 was
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embryos injected with 4 ng arl6ip1-MO1 together with 100 pg
GFP mRNA (n=112), whereas the expression of GFP was totally
absent in the embryos injected with 4 ng arl6ip1-MO1 together
with 100 pg arl6ip1-MO1-target- gfp RNA synthesized from pCS2-
Arl6ip1-GFP (n=115) (Figs. S1D and H). This line of evidence
indicated that arl6ip1-MO1 was capable of specifically blocking the
translation of arl6ip1 mRNA and that the defects induced by
arl6ip1-MO1 were specific and could be rescued by wobble arl6ip1
mRNA.
Pharyngeal arch development is abnormal in arl6ip1
morphants
When Arl6ip1 was knocked down, the mandible was reduced,
as mentioned above. The majority of the head skeleton is derived
from the cranial neural crest cells which migrate to the branchial
arches and frontonasal process. Therefore, we speculate that the
shortened mandible of arl6ip1 morphants may have resulted from
defective craniofacial cartilages. To test this hypothesis, we
performed Alcian blue staining to observe the craniofacial
cartilage of the 4-dpf embryos. The craniofacial cartilages, such
as mandibular (1st arch), hyoid (2nd arch) and ceratobranchial
(3rd–7th arches), which are all derived from three streams of
cranial NC [27], were all clearly shown (Fig. 2A). In contrast, no
cartilages for any of the arches were apparent in either the arl6ip1-
MO1-injected embryos or arl6ip1-MO1/p53-MO-injected embry-
os (Figs. 2C and 2D). The occurrence rate of neurocranium
defects, either in the 4 ng arl6ip1-MO1-injected embryos or in the
4n garl6ip1-MO1/6 ng p53-MO- injected embryos, was 100%
(133/133 in arl6ip1-MO1 embryos; 146/146 in arl6ip1- MO1/
p53-MO embryos). Moreover, severe shortening of trabeculae and
complete loss of ethmoid plate (Fig. 2C), which are from anterior
neurocranial cartilage, were also observed in the arl6ip1-MO1-
injected embryos. However, wild-type embryos displayed a well-
organized anterior neurocranial cartilage (Fig. 2B). It should be
noted that both of these cartilages were derived from NC for the
development of neurocranium. Finally, arl6ip1-MO1/p53-MO-
injected embryos exhibited the same craniofacial phenotypes as
the arl6ip1-MO1-injected embryos (Fig. 2D), except for the larger
head size. Furthermore, the severe craniofacial defect, which is
shown in Figures 2D, could be rescued in wobble arl6ip1 mRNA-
injected embryos (Fig. 2H). Since the co-injection of p53-MO was
used to rule out nonspecific effect by MO-toxicity [26], we are
satisfied that these arl6ip1-MO1/p53-MO co-injection data
indicated that the complete loss of both pharyngeal arches and
ethmoid plate with shortened trabeculae could not be attributed to
either cell death or the nonspecific effects of arl6ip1-MO1. Instead,
Arl6ip1 was clearly demonstrated to function in NC derivative
arches.
Figure 1. Embryos injected with arl6ip1-MO1 display abnormal development in ectoderm-derived tissues. Lateral views of embryos at
24 hpf (A–C), 48hpf (D–F) or at 96 hpf (G–L). (A) Wild-type (WT) embryos at 24 hpf displayed normal embryonic morphology. (B) Embryos injected
with arl6ip1-MO1 exhibited foreshortened yolk extension and tail and small head with eye lesions. These embryos were defined as having severe
defects. (C) Embryos with mild defects showed longer axis than embryos with severe defects. However, similar to embryos with severe defects, eye
development was nearly equally compromised. (D) At 48hpf, WT embryos displayed plentiful melanophores. (E, F) Melanophores were highly
reduced in arl6ip1-MO1 and arl6ip1-MO1/p53-MO-injected embryos. (G) Iridophores (arrows) were prominent in 4 dpf WT embryos. (H) Iridophores
were almost absent in arl6ip1-MO1 embryos (only 1 residual cell was seen here in the ventral of the trunk) and (I) highly reduced in arl6ip1-MO1/p53-
MO-injected embryos. (J) WT embryos showed well-developed head, jaw and melanophores. (K, L) arl6ip1-MO1 and arl6ip1-MO1/p53-MO-injected
embryos displayed reduced head size and jaw (double arrows), but the head of arl6ip1-MO1/p53-MO embryos was bigger than arl6ip1 morphants.
doi:10.1371/journal.pone.0032899.g001
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required for jaw development and is expressed by NC cells, which
contribute to the pharyngeal arches, as well as by migratory arch-
associated NC cells. While we found a marked increase of dlx2
expression in the migratory NC pharyngeal arch precursors in
wild-type zebrafish embryos (Fig. 2E), we also found that dlx2 was
markedly reduced in the migratory NC cells destined for the
posterior arches of the arl6ip1 and arl6ip1/p53 morphants (Figs. 2F
and G), suggesting that reduced dlx2 expression in the morphants
is responsible for the defective craniofacial cartilages. Further-
more, the expression pattern of dlx2 in the forebrain of arl6ip1-
MO1-injected embryos was similar to that of wild-type embryos,
indicating that the differentiation in the forebrain was normal.
NC derivatives are reduced in arl6ip1-deficient embryos
The occurrence of defective cartilages in the arl6ip1-MO1-
injected embryos strongly suggested that arl6ip1 may play a role in
NC development. To test this hypothesis, we used an anti-Hu
immunofluorescence assay to examine the cranial ganglia




concentration Defects (%) Wild-type-like
Severe Mild
2 ng — 14.3(12/84) 42.9(36/84) 42.9(36/84)
4 ng — 35.5(55/155) 48.4(75/155) 16.1(25/155)
6 ng — 41.1(46/112) 55.4(62/112) 3.6(4/112)
4n g +150 pg arl6ip1 mRNA — 11.9(13/109) 32.1(35/109) 56.0(61/109)
4n g +200 pg arl6ip1 mRNA — 5.4(8/148) 17.6(26/148) 77.0(114/148)
— 6 ng — 1.9 (2/105) 98.1 (103/105)
— 8 ng — 4.2(5/118) 95.8(113/118)
4 ng 6 ng 11.5(12/104) 74.0(77/104) 14.4(15/104)
4n g +75 pg arl6ip1 mRNA 6 ng 5.3(6/113) 34.5(39/113) 60.2(68/113)
4n g +150 pg arl6ip1 mRNA 6 ng 2.4(4/166) 17.5(29/166) 80.1(133/166)
4n g +0.2 pg foxd3 mRNA 6 ng 13.6(12/88) 61.2 (54/88) 25.0 (22/88)
4n g +0.4 pg foxd3 mRNA 6 ng 16.2(12/74) 51.4(38/74) 32.4(24/74)
The morphological defects of embryos were observed at 36 hpf. Severe defects are defined as those where the brain did not form sulcus and gyrus in the heada n d
where the axis appeared as a curved shape in the trunk of embryos. Mild defects are defined as those where the embryonic axis was longer than observed in embryos
with severe defects, but where head defects were just as severe. The arl6ip1 mRNA used in this study was synthesized as a wobble form.
doi:10.1371/journal.pone.0032899.t001
Figure 2. Craniofacial cartilage defects in the arl6ip1 morphants. Ventral views (A, C, D, H) or dorsal view (B) of 4-dpf embryos stained with
Alcian blue to reveal craniofacial cartilage. Either pectoral fin (pf) or cartilage derived from mandibular (1st arch, m), hyoid (2nd arch, h), and
ceratobranchial (3rd–7th arches, cb) arches was observed in control embryos (A). Dorsal views of anterior neurocranial cartilage in wild-type embryos
showed paired trabeculae (tc) and an ethmoid plate (ep) (B). However, craniofacial cartilage and pectoral fin were absent in the arl6ip1-deficient (C)
and arl6ip1-MO1/p53-MO-injected embryos (D). In the anterior neurocranial cartilage, trabeculae were severely reduced in both of these embryos,
and the ethmoid plate was absent (C, D). dlx2 was expressed in migratory neural crest precursors of pharyngeal arch, as shown in dorsal views at 36
hpf in wild-type (E). Both arl6ip1-MO1-injected (F) and arl6ip1-MO1/p53-MO-injected embryos (G) had reduced dlx2 expression, and the reduction of
dlx2 was prominent in posterior arches at 24 hpf. In addition, dlx2 was expressed normally in the forebrain (E, F, G). The severe chondrocranium and
pectoral fin defects in arl6ip1-MO1/p53-MO-injected embryos were rescued by injection of 75 pg wobble arl6ip1 mRNA (H). bp, basal plate; pbc,
posterior basic capsular commiss. Arrows, pectoral fin.
doi:10.1371/journal.pone.0032899.g002
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neurons in the trunk, since these ganglia have NC origin. Results
showed a severe reduction of neurons in epibranchial ganglia,
dorsal root ganglia and enteric ganglia, and a mild reduction of
neurons in trigeminal ganglia, either in the arl6ip1 or arl6ip1/p53
morphants (Figs. 3B, C, E and F). The occurrence rates of cranial
ganglia, dorsal root ganglia and enteric neuron defects in the 4 ng
arl6ip1-MO1-injected embryos were 68.3% (71/104), 72.5% (132/
182) and 73.8% (48/65), respectively. These data indicated that
cranial, vagal and trunk neurons, which are derived from the NC,
were defective in the arl6ip1-MO1-injected embryos. We also
detected a large number of Hu-positive cells in the head of arl6ip1-
MO1-injected embryos (Fig. 3B). To explain this observation, we
suggest that antibody penetration into the brain of morphants is
more efficient, making brain neurons more visible.
Arl6ip1 is required for the specification of NC sublineages
To study the function of arl6ip1 during NC development, we
first detected the expressions of the ectodermal patterning factors
wnt8, bmp4, pax3, and msxb. The ectodermal patterning factors
were all normally expressed in the arl6ip1-MO1- injected embryos
(Figs. 4A and F; 4B and G; 4C and H; 4D and I). In addition, the
expression of the pre-placodal marker dlx3b was also normal in the
arl6ip1-MO1- injected embryos (Figs. 4E and J, n=64). Further-
more, since Trainor and Krumlauf (2000) [28] reported that
segmentation and patterning of the hindbrain are necessary for
cranial NC development; we also examined the expressions of two
hindbrain patterning markers, fgf3 and fgf8. Results showed that
fgf3 and fgf8 were also expressed normally in the hindbrain of
arl6ip1 morphants (Figs. S2A–D, n=87) and that 83.2% of
morphants exhibited a normal hindbrain segmentation at 24 hpf
(Figs. S2E–F, n=101). These findings suggested that the induction
of both early NC progenitors and placodal region cells results in
normal development of arl6ip1 morphants. The early patterning
and later segmentation of the hindbrain in the arl6ip1-MO1-
injected embryos were also similar to those of wild-type. Thus,
even though arl6ip1 may not function in hindbrain development, it
is expressed ubiquitously until 24 hpf, and knockdown of Arl6ip1
did cause small head morphology. This line of evidence suggests
that neural crest defects in arl6ip1-MO1 embryos did not result
from abnormal head development. On the other hand, when we
observed the expressions of pre-migratory NC markers in the
progenitors of the neural plate border, such as tfap2a, foxd3, snai1b,
and sox10, we found that the expressions of foxd3, snai1b and sox10
were greatly reduced in the arl6ip1 morphants at 3-somite (Figs. 5B
and F; 5C and G; 5D and H) through 8-somite stages (Figs. 5I and
L; 5J and M; 5K and N). Meanwhile, tfap2a expression in NC
progenitors was present in both wild-type and arl6ip1-MO1
embryos (Figs. 5A and E). Double-staining of sox2 (labeling neural
plate) and dlx3b (labeling the pre-placodal region) exhibited a
patch of unlabeled cells between these two expression domains
which was presumed to be the NC. Thus, since the induction of
presumptive NC was normal in arl6ip1-MO1 embryos (Fig. S3), we
concluded that NC induction occurred normally in arl6ip1
morphants. The occurrence rates of down-regulation of foxd3,
snai1b and sox10 in the arl6ip1-MO1-injected embryos were 75.6%
(31/41), 82.2% (37/45) and 66.7% (30/45), respectively. Again,
since down-regulation of these genes could have resulted from
early cell death by the off-targeting effect of MO, we injected 6 ng
p53-MO together with 4 ng arl6ip1-MO1 to inhibit apoptosis and
nonspecific effects. We found that the level of cell death was
dramatically reduced in the embryos injected with p53-MO. In
addition, Cole and Ross (2001) [29] have detected the temporal
and spatial distribution of apoptotic cells during normal develop-
Figure 3. Neural crest derivatives are reduced in arl6ip1-deficient embryos. Lateral views (A–F) of 72 hpf embryos processed for anti-Hu
immunofluorescence assaying (IFA) to reveal the derivatives of cranial neural crest cells by confocal micrographs. In control embryos (A, D), anti-Hu
IFA-labeled trigeminal ganglia (tg), epibranchial ganglia (ep), dorsal root ganglia (drg) (arrowhead), enteric neurons (arrow) all appeared to be
reduced either in arl6ip1 knockdown embryos (B, E) or arl6ip1-MO1/p53-MO-injected embryos (C, F).
doi:10.1371/journal.pone.0032899.g003
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their data, only a few apoptotic cells could be seen in the optic
vesicle at 12hpf, and no apoptosis was observed in the pre-
migratory neural crest cell region. Robu et al. (2007) [26] also
demonstrated that about 15–20% of MO used in zebrafish show
off-targeting effects, as represented by a signature neural death
peaking at the end of segmentation (1 dpf). They also showed that
the neural cell death induced by MO was observed as early as 14
hpf. Moreover, Ekker and Larson (2001) [30] indicated that the
onset of cell death induced by MO technology was 14 hpf. In our
data, we detected pre-migratory neural crest markers at the 3-
somite stage (about 10.33 hpf), even earlier than 12 hpf;
consequently, we did not observe off-targeting effects at the 3-
somite stage. On the other hand, when p53 was inhibited, cell
survival could not rescue expressions of foxd3, snai1b and sox10 at
the 8-somite stage (Figs. 5L–N). Therefore, we concluded that the
down-regulation of these gene markers in existing NC cells was
caused by defects in NC derivate specification, not cell death.
Furthermore, such defects subsequently resulted in the reduction
of the cell population, especially in pharyngeal arches of cranial
NC sublineages. Finally, we found that the reduced expression of
foxd3 induced by arl6ip1-MO1 could be restored by injection of
wobble arl6ip1 mRNA in arl6ip1- MO1-injected embryos (Figs.
S4A–C). These findings implicated that Arl6ip1 plays a key
function in specification of NC sublineages, but not induction.
Trunk NC migration is defective, and cranial NC is
reduced in the arl6ip1 morphants, as co-tested with
myod staining
In wild-type zebrafish embryos, the migration of cranial NC has
three distinctstreams:migrationfrom rhombomeres(r)r2,r4andr6
tomandibular(1st arch),hyoid (2nd arch)andceratobranchial(3rd–
7tharches),respectively.WewereabletodetectthesemigratoryNC
streams by crestin probe (Fig. 6A). In the arl6ip1-MO1-injected
embryos at 24 hpf, the crestin expression in the cranial crest was
reduced in the 3rd NC stream, and crestin was almost absent in the
1st and 2nd stream, as shown in Figure 6D. The reduced expression
of crestin in cranial NC cells resulted in defective craniofacial
cartilages, which also was proved by previous data of dlx2, as shown
in Figure 2. The occurrence rate of reduced defects in the crestin-
labeledcranialNCwas73.4%(47/64).However,thetrunkNCcells
in the arl6ip1 morphants appeared to have defects in NC migration.
Because severe trunk extension and somite defects could indirectly
affect trunk neural development, such as cell migration, we used
arl6ip1 and arl6ip1/p53 morphants with only mild defects impeding
normal trunk development to analyze the migration of trunk NC.
Compared to wild-type embryos, there was a significant delay in the
onset of migration of the arl6ip1 morphants, which had only a small
number of ctn-expressing cells migrating within the most anterior
somites (Figs. 6B and E). Similarly, the sox10 gene, which is also
expressed in migrating trunk NC cells [31], showed a delay in NC
migration in the arl6ip1-MO1-injected embryos at 24 hpf (Figs. 6C
and F). Compared to wild-type embryos, the cell numbers in trunk
NC of arl6ip1-MO1-injected embryos were normal, but these cells
could not migrate. The occurrence rates of migration defects in the
sox10- and crestin-labeled trunk NC were 72.7% (40/55) and 75%
(45/60), respectively. Co-injection of arl6ip1-MO1 with p53-MO in
embryos showed the same migration defects as the arl6ip1-MO1-
injected embryos (Figs. 6H and I). To quantify the number of
streams of crestin-positive NC cells which migrate through the trunk,
we observed that the inhibition of migrating streams of NC cells
from the dorsal neural tube was exhibited in the arl6ip1 morphants
(Fig. S4G). Again, injection of a wobble arl6ip1 mRNA rescued
embryos from these defects (Figs. S4D–F and S4G). When we
traced the expressions of crestin and sox10 at 30 hpf, we found that
thestreamsofsox10- andcrestin-labeledcellsinthearl6ip1morphants
still could not migrate normally when compared to the wild-type
embryos (data not shown). This evidence revealed that trunk NC
cells remained localized between the dorsal surface of the neural
keel and overlying ectoderm in the arl6ip1-MO1-injected embryos
(Figs. 6E and F). In summary, the defects shown in dorsal root
ganglia clearly resulted from the inhibition of trunk NC migration.
To further understand why enteric neurons were absent in the
arl6ip1-deficient embryos, as shown in Figure 3D, we examined
vagal NC migration. We observed embryos at 36 hpf and found
that the crestin-labeled NC cells of wild-type embryos migrated out
of the vagal region (Fig. 7A). However, the crestin-labeled NC cells
of arl6ip1-MO1-injected and arl6ip1-MO1/p53-MO-injected em-
bryos did not migrate normally and showed decreased progenitor
cell numbers when compared to the wild-type (Figs. 7B and C).
Additionally, we observed that the enteric nervous system (ENS)
precursors labeled by phox2b were distributed along the entire
length of intestine from 48 to 72 hpf in wild-type embryos (Figs. 7D
Figure 4. Expressions of ectodermal patterning factors appear normal in arl6ip1-MO1-injected embryos. Dorsal views of wild-type (A–E)
and arl6ip1 morphant (F–J) embryos at the 3-somite stage. Anterior to the top. The neural ectodermal patterning factors of wnt8 (A, F), bmp4 (B, G),
msxb (C, H), dlx3b (D, I), and pax3 (E, J). Normal expressions of these genes reveal that ectodermal patterning factors are not affected in arl6ip1
morphants, suggesting that Arl6ip1 does not have a role in ectodermal patterning. Scale bar: 100 mm.
doi:10.1371/journal.pone.0032899.g004
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migrated to the anterior part of the intestine in arl6ip1 morphants
and arl6ip1/p53 morphants (Figs. 7E and F; 7H and I). The
occurrence rate of migration defects in the phox2b-labeled enteric
neurons was 88.7% (63/71). We suggested that this migratory
delay and partial loss of enteric precursors would affect normal
differentiation of enteric neurons and might lead to loss of the
ENS.
Disruption of zebrafish Arl6ip1 function resulted in cilia
defects and dampened Hedgehog signaling
During migration, Shh directs migration and patterning of NC
cells. Tobin et al. (2008) [24] indicated that knockdown of BBS
disrupted the Sonic Hedgehog (Shh) signaling pathway and
affected NC cell migration. Therefore, we investigated Shh
signaling in arl6ip1 morphants. The results showed that shh
expression was unaltered in arl6ip1-MO1/p53-MO-injected em-
bryos (Fig. S5B); however, pax6, normally repressed by Shh
signaling, was up-regulated and ectopically expressed throughout
the neural tube in arl6ip1-MO1/p53-MO-injected embryos (Fig.
S5D). The occurrence rate of overexpressed pax6 in the in the
neural tube was 78.4% (69/88). We therefore concluded that the
Shh signaling pathway might be perturbed in arl6ip1-MO1/p53-
MO-injected embryos. In addition, Shh signaling reveals a cell
autonomous requirement for Hh signal transduction and is
directly required for normal development of DRG neurons in
zebrafish [32]. Thus, the defects shown in dorsal root ganglia
(Fig. 3) clearly resulted from disrupted Shh signaling pathway.
Figure 5. The markers of pre-migratory neural crest cells are down-regulated in arl6ip1-MO1-injected embryos. Dorsal views of 3-
somite-stage wild-type (A, B, C, D) and arl6ip1 knockdown embryos (E, F, G, H), or 8-somite-stage wild-type (I, J, K,) and arl6ip1 knockdown embryos
(L, M, N) were shown to reveal the indicated markers. Neural plate border was indicated with the expression of tfap2a (A, E), foxd3 (B, F), snai1b (C, G)
and sox10 (D, H). Decreased expression of these markers, except tfap2a, was evident and predominant in arl6ip1 morphants. Arrows indicate position
of midbrain-hindbrain boundary. (I–K) At the 8-somite stage, these markers were expressed predominantly in early migrating cranial neural crest cells
(indicated by brackets). (L–N) These genes were reduced in embryos co-injected with 4 ng arl6ip1-MO1/6 ng p53-MO, especially in foxd3 and snai1b
expression.
doi:10.1371/journal.pone.0032899.g005
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signaling [33]. Furthermore, overexpression of GDP- or GTP-
locked variants of ARL6/BBS3 in a ciliated cell line, namely
retinal pigmented epithelial cells (hTERT-RPE), influences
primary cilium length and abundance [34]. Therefore, we
additionally determined whether cilia of arl6ip1-MO1/p53-MO-
Figure 6. Abnormal cell migration in arl6ip1-MO1-injected embryos. Wild-type (A–C), arl6ip1-MO1-injected (D–F) and arl6ip1-MO1/p53-MO-
injected (G–I) embryos were shown under dorsal views at 20-hpf (A, D, G) and under lateral views at 26-hpf (B, C, E, F, H, I), anterior to the left. Crestin
expression revealed the migration of the three cranial neural crest streams in the wild-type embryos at 20 hpf (A). In arl6ip1 and arl6ip1/p53
knockdown embryos, crestin expression in the cranial crest was reduced in the 3rd neural crest stream and almost absent in the 1st and 2nd stream
(D, G). At 26 hpf, the trunk migratory neural crest cells in wild-type embryos, as labeled by crestin and sox10, gradually migrated to ventral (B, C).
However, the sox10- and crestin-expressing cells in arl6ip1 knockdown and arl6ip1-MO1/p53-MO-injected embryos failed to migrate ventrally (E, F, H,
I).
doi:10.1371/journal.pone.0032899.g006
Figure 7. Enteric nervous system of arl6ip1 morphants is degenerated. Wild-type (WT) embryos (A, D, G), arl6ip1-MO1-injected embryos (B, E,
H), and arl6ip1-MO1/p53-MO-injected embryos (C, F, I) were observed under dorsal view at 36-hpf (A–C) and under lateral view at 48 hpf (D, E, F) and
72 hpf (G, H, I). Neural crest cells (NCCs), which were labeled by crestin probe (arrowheads in A), of WT embryos exited the vagal region and migrated
to the enteric region. However, the crestin-labeled NCCs of arl6ip1-MO1-injected and arl6ip1-MO1/p53-MO-injected embryos remained in the vagal
region (B, C). Compared to WT embryos, either the arl6ip1-MO1-injected embryos or arl6ip1-MO1/p53-MO-injected embryos exhibited shortened
enteric neurons and delayed migration (D vs. E; D vs. F; distance between two arrows). Additionally, the phox2b-positive enteric neurons were
distributed throughout the entire gut to the anus (G). Arrows indicate the most posterior region of migration, and the asterisks represent the anus.
The enteric neurons of arl6ip1-MO1-injected embryos and arl6ip1-MO1/p53-MO-injected embryos all failed to reach as far as the anus (H, I).
doi:10.1371/journal.pone.0032899.g007
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abundant, evident and aggressive cilia in zebrafish. By confocal
immunostaining of acetylated tubulin in 8-somite stage embryos,
apical cilia in the KV were shortened and reduced in number in
arl6ip1-MO1/p53-MO-injected embryos compared with the wild-
type embryos (Figs. S6I and J). The occurrence rate of reduced
KV was 51.6% (49/95). Since zebrafish KV plays a role in left-
right patterning [35], we tested whether cilia defect in KV resulted
in laterality defects by assaying expression of two conserved left-
right genes, southpaw (spaw) and pitx2. Significantly, arl6ip1-MO1/
p53-MO-injected embryos showed randomized expression of spaw
and pitx2 (Figs. S6A–H and S6K). Finally, following the method
reported by Amack and Yost (2004) [35], we injected fluorescence-
tagged arl6ip1-MO1 into embryos between 2 to 4 hpf and selected
embryos whose MOs had accumulated into dorsal forerunner cells
(DFC) to determine if Arl6ip1 was required for KV morphogen-
esis. The occurrence rate of mid-blastula-injected MOs, which
were incorporated into DFC, was 42% (n=435). The results
showed that DFC of arl6ip1-MO1-injected embryos displayed
reduced KV (65%, n=133) and even failed to form KV (23%,
n=133). Thus, cilia were disorganized in the KV of DFC of
arl6ip1-MO1-injected embryos (Fig. S7). Taken together, we
demonstrated that Arl6ip1 is required for KV morphogenesis
and that shh signaling may be perturbed by defective cilia, in turn,
leading to the perturbation of NC cells migration and left-right
laterality.
Loss of Arl6ip1 function causes cell death in embryos, but
not in NC at later stage
In arl6ip1-deficient embryos, pharyngeal arches, dorsal root
ganglia and enteric neurons at the later stages of embryonic
development were severely reduced or absent. The loss of these
cells during development might result from cell death. To
investigate the role of Arl6ip1 in NC survival, TUNEL assay
was performed to examine cell death. At the 3-somite stage, there
were no significant TUNEL signal differences in cell death
between wild-type and arl6ip1-MO1-injected embryos (Figs. 8A
and D). However, we detected a great increase of TUNEL-positive
cells around the dorsal ectoderm in arl6ip1-MO1-injected embryos
from the 3- to 15-somite stages, compared to wild-type embryos
(Figs. 8B and E; 8C and F). The expression of pre-migratory NC
markers was also severely reduced in the arl6ip1-MO1 embryos
between the 3- and 8-somite stages (Fig. 5). We detected a great
increase of TUNEL-positive cells around the dorsal ectoderm in
arl6ip1-MO embryos from the 3- to 15-somite stages, and this
increase ended at 36 hpf. To confirm whether these dying cells
were overlapped with crestin-positive NC cells, we performed
double- labeling with crestin and fluorescent TUNEL (Figs. 8G–I;
G9–I9). The significant expression of crestin in wild-type embryos
indicated that cranial NC appeared at the anterior region of trunk
somites at this stage (Figs. 8G and G9, indicated by arrows). When
we compared dying cells with crestin-positive NC cells using
double-labeling assay in arl6ip1-MO1-injected embryos, apoptotic
cells tended to localize at the more anterior and superficial region,
while crestin-positive NC cells were inclined to localize at the
posterior region (Figs. 8H and H9). Since cell death occurring in
arl6ip1-MO1-injected embryos was inhibited by p53-MO, cell
death was observed to be correspondingly decreased in the arl6ip1-
MO1/p53-MO-injected embryos (Fig. 8I). Compared with wild-
type embryos, we also found the number of crestin-positive cells in
arl6ip1-MO1-injected embryos and arl6ip1-MO1/p53-MO-inject-
ed embryos to be reduced (Figs. 8G9 vs. 8H9;8 G 9 vs. 8I9, indicated
by brackets). In addition, most crestin-positive cells failed to show
cell death signaling in arl6ip1-MO1-injected embryos (Figs. 8H
and H9). To account for the overlapping signals of crestin- and
TUNEL-positive cells under fluorescent stereomicroscopy, we
found an average of 9.6, 6.7 and 1.9 out of 10 cells to be positive to
both TUNEL and crestin signals in arl6ip-MO1-injected embryos,
wild-type embryos, and arl6ip1-MO1/p53-MO- injected embryos,
respectively. However, the appearance of TUNEL-positive cells
did not correlate with most crestin-labeled cells at this stage, which
could be attributed to other defects in the arl6ip1 morphants. Thus,
we concluded that cell death does not play a role in the NC
survival of arl6ip1-MO1-injected embryos.
Discussion
In this study, we are the first to investigate the novel function of
Arl6ip1 in NC development of zebrafish. Specifically, by using
arl6ip1-specific MO, we demonstrated that NC induction occurs
normally, but Arl6ip1 is required for specification of sublineages
within the NC. In the arl6ip1-deficient embryos, we found that the
expressions of dlx2 and crestin in three streams of cranial NC are
almost absent, resulting in marked craniofacial defects. Moreover,
these defects are not confined to the craniofacial region. Rather,
vagal-derived NC cells also fail to populate the enteric nervous
system of arl6ip1-deficient embryos. We also showed a significant
delay in the onset of migration in the trunk, and we demonstrated
that such delay causes defects in dorsal root ganglia and synthesis
of pigment cells in the arl6ip1 morphants. Finally, the defects of
arl6ip1 morphants could be restored by injecting wobble arl6ip1
mRNA. However, the degree of rescue by increasing arl6ip1
mRNA concentration alone is not as effective as injecting arl6ip1
mRNA/p53-MO. While it was concluded that arl6ip1-MO1 might
have some off-targeting effects in embryos, arl6ip1-MO1/p53-MO
co-injection could prevent these nonspecific effects. Therefore, all
MO experiments carried out in this study used arl6ip1-MO1/p53-
MO co-injection, except those unaltered genes in arl6ip1-MO1
embryos. Most importantly, our results clearly demonstrated that
Arl6ip1 plays a key functional role in NC migration and
specification of sublineages, which points to the likelihood of its
association with Hirschsprung’s disease and with the aberrant
craniofacial characteristics of BBS.
In mouse, arl6ip1 is expressed in all hematopoietic cell lineages,
and Arl6ip1 protein is localized to intracytoplasmic membranes
[21]. By analysis of the cellular location of arl6ip1 expression,
Pettersson et al. (2000) [21] suggested that arl6ip1 may play a role
in protein transport, membrane trafficking, or cell signaling during
hematopoietic maturation. Lui et al. (2003) [22] also demonstrated
that ARMER/Arl6ip1 is a novel ER integral membrane protein
which protects cells by inhibiting caspase-9 activity, thereby
revealing a possible role for ARMER in cell survival. Interestingly,
in this study, we demonstrated that zebrafish arl6ip1 is expressed
ubiquitously through 24 hpf and plays a critical role in NC
migration and specification of derivatives, rather than hematogen-
esis. By loss-of-function studies, the results presented in this report
strongly support the hypothesis that zebrafish Arl6ip1 performs
key functions in NC development, including derivates specification
and migration, but not induction. Since Arl6 is a major regulator
involved in BBS, the implications for human disease become
obvious, particularly as they relate to neuropathic disorders.
In a previous report, genetic studies showed that foxd3 is
expressed normally in the pre-migratory neural crest cells of the
sox10 (colorless) mutant [36], suggesting that foxd3 may function as
an upstream effector of sox10. This hypothesis is supported by
Kelsh and Eisen (2000) [36], Elworthy et al. (2005) [37] and
Stewart et al. (2006) [38], who demonstrated the effect of foxd3 on
the sox10-dependent genetic pathway, where foxd3 mutants (sym1
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than sox10 mutants, with the exception of chromatophores.
Therefore, based on the genetic analysis presented in this study,
it is plausible to theorize that arl6ip1 may regulate the specification
of NC derivatives through activation of other pre-migratory NC-
specific transcription factors, such as sox10 or foxd3.
Another mutant found to affect foxd3 function is mosm188.A
complementation analysis with the sym1/foxd3 mutant found that
the two mutations affect the same locus. Sequencing the foxd3
coding region in mosm188 mutants did not display any nucleotide
changes, suggesting that mosm188 most likely impairs either foxd3
mRNA expression or stability. Furthermore, since mosm188
mutants express foxd3 ectopically in somites or in gastrula, but
not in NC cells, it is likely that the mosm188 mutation knocks out
an NC-specific regulatory element within the foxd3 locus [39]. This
mutant also showed the same depletion of NC derivatives as sym1
mutation, including craniofacial cartilage, sympathetic neurons,
dorsal root ganglia, enteric neurons, and pigment cells. Moreover,
it was also reported that the foxd3 gene might act to maintain the
undifferentiated state of NC progenitors during embryogenesis. In
the absence of Foxd3, it is thought that some NC cells prematurely
differentiate, thus producing fewer progenitor cells and leading, in
turn, to the normal development of fewer derivatives. Although
Arl6ip1 may act upstream of Foxd3 and Sox10 (Fig. 6),
knockdown of Arl6ip1 still reduces the number of both sox10-
and foxd3-expressing NC progenitors. Thus, Arl6ip1 knockdown
causes more serious developmental defects in the reduction, or
absence, of NC derivatives than sox10 and foxd3 mutants.
Furthermore, since Snail family members can affect early NC
development in other species [40,41,42], the severe reduction of
snai1b expression in arl6ip1 morphants in NC subpopulations may
also contribute to the neuronal and glial defects. However, since
snai1b function has not yet been uncovered in zebrafish, it remains
to be elucidated whether the snai1b gene also differentially
regulates NC specification.
We found that both abnormal trunk extension and somite
defects were induced by arl6ip1-MO1. Thus, it is possible that
arl6ip1-MO1-injected embryos undergo mispatterning of somitic
regions, causing a significant loss of cells in these regions that
would otherwise provide guidance or survival cues to the trunk
migrating NC cells. These defects could also be indirectly affected
by trunk neural development, such as cell migration. Furthermore,
Robu et al. (2007) [26] stated that p53 knockdown by itself did not
induce any significant defects, as p53 is not required for normal
development in mammals or fish (see Figures 1B and 2B of Robu et
al., 2007). In the present study, p53-MO did not affect the efficacy
of gene-specific MOs, as it did not interfere with the penetrance of
gene-specific phenotypes. Our findings also clearly showed that
head size and trunk extension were recovered in arl6ip1-MO1/
p53-MO-injected embryos at 24 hpf. In addition, we also
confirmed that myod was expressed normally, either in wild-type
or arl6ip1-MO1/p53-MO-injected embryos, at 24 hpf (data not
shown). Thus, we used either arl6ip1 or arl6ip1/p53 morphants
with only mild defects impeding normal trunk development and
co-tested with myod staining to analyze the migration of trunk NC.
Finally, we demonstrated that trunk NC migration, either in
arl6ip1 or arl6ip1/p53 morphants, is defective.
The regulation of cell death by Arl6ip1 may be a conserved
function. Lui et al. (2003) [22] gave evidence of this essential role in
cell survival by induced overexpression of human Arl6ip1 in cell
line HT1080. Briefly, their work demonstrated that human
Arl6ip1 plays a possible role in cell survival by inhibiting
caspase-9 activity. Recent studies have shown that Snail family
members also play a role in the survival of progenitor cell
populations and are overexpressed in some human cancers
[43,44,45]. In our studies, however, double-labeling with crestin
and TUNEL in arl6ip1-MO1 embryos showed that just a few of
the dying cells were crestin-positive. Thus, zebrafish Arl6ip may
play a role in cell death, but not in NC survival.
Figure 8. Cell death does not cause the loss of neural crest cells. Lateral views of TUNEL-labeled wild-type (WT) embryos (A–C) or arl6ip1-
MO1-injected embryos (D–F) at 3-somite stage (A, D), 8-somite stage (B, E), and 15-somite stage (C, F), respectively. (A, D) There were no TUNEL-
positive cells in WT and arl6ip1-MO1 embryos. (B, C, E, F) Compared to WT embryos, arl6ip-deficient embryos displayed a significant increase of
TUNEL-positive cells in the dorsal region of embryos at the 8- and 15-somite stages (indicated by arrowheads) (B and C vs. E and F). (G, H, I) Double-
labeling analysis with crestin (dark blue) and TUNEL (red fluorescent) showed that only limited cell death occurred at the expression region of crestin.
(G9,H 9,I 9) The views of the embryos shown in panels G9,H 9 and I9 were at higher magnification.
doi:10.1371/journal.pone.0032899.g008
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surface of the neural keel and overlying ectoderm in the arl6ip1-
MO1 embryos, defects in dorsal root ganglia clearly resulted from
the inhibition of trunk NC migration. Similarly, reduced numbers
of dorsal root ganglia are to be found in the zebrafish sym1 mutant.
Stewart et al. (2006) [38] demonstrated that foxd3 functions to
specify neuronal and glial sublineages and is required for the
timing of trunk NC migration. Furthermore, decreased expression
of sox10, snai1b and ctn was evident in sym1 mutants. It is
worthwhile noting that down-regulation of early NC specifiers
may also affect the migration of the NC cells at the later
embryonic stage. This result is also consistent with recent studies in
chick showing that foxd3 function is required for NC migration by
regulating the expression of cell-cell adhesion molecules
[46,47,48]. Therefore, the results of our zebrafish study are in
agreement with those findings in chick and sym1 mutants since we
found that foxd3 retains sufficient expression in the somite of
zebrafish embryos at 30 hpf to inhibit trunk NC migration (data
not shown).
The early NC phenotype reported here is severe at the 3-somite
stage (Fig. 5), yet the NC phenotype reported later in development
(Fig. 6) appears much less severe. We do not think that the NC
phenotypes, which are much less severe in later development, as
shown in Figure 6, are a consequence of developmental delay. All
the NC sublineages are derived from the pre-migratory cell pool at
the 3-somite stage, but no clear region can be found indicating
localization of the pool of pre-migratory cells that might contribute
to the subset of NC sublineages. However, based on the defective
NC derivatives which occurred in the arl6ip1-MO1-injected
embryos, we learned which NC sublineages are affected.
Consequently, in this study, we hypothesized that the subset of
NC sublineages of trunk was less affected by the knockdown of
Arl6ip1 in the pre-migratory NC pool. In contrast, the subsets of
vagal and cranial NC cells were greatly reduced in the pre-
migratory NC pool of arl6ip1-MO1-injected embryos. Therefore,
at the later developmental stages, development of both vagal-
derived enteric neurons and cranial-derived pharyngeal arches
was highly reduced in cell numbers. On the other hand, the trunk
NC cells appeared much less affected in terms of cell number.
Knecht and Bronner-Fraser (2002) [49] reported that Wnt,
Bmp2/4 and TGFb 1, 2 and 3 signaling pathways induce
multipotent NC progenitor cells and that the newly specified pre-
migratory NC progenitors express a unique set of transcription
factors, such as Foxd3, Snai1b, Id2, Sox10 and Tcfap2a.
Subsequently, the NC cells turn off early markers, like Sox10,
up-regulate a new set of genes, and begin to migrate. At this stage,
NC cells derived from the hindbrain migrate as a wave in a caudal
direction. The first group of cells starting to migrate includes the
cells populating in the pharyngeal arches. This first group of cells is
followed by a second wave of migration which supplies cells to
trunk NC [50]. In Figures 5F–H, we can clearly observe that the
pre-migratory NC of midbrain-hindbrain boundary in the arl6ip1-
MO1-injected embryos was only slightly affected. On the other
hand, the trunk NC cells could not migrate ventrally in the arl6ip1-
MO1-injected embryos. However, the proliferation of trunk NC
cells may be normal, resulting in non-migrated trunk NC cells
populating the dorsal neural tube. This continuous proliferation of
trunk NC cells recovers the loss of the NC cells in the early
developmental stages. Actually, the subsets of vagal and cranial
NC cells do not recover at all. These findings might plausibly
explain why the trunk NC cell numbers were less severe.
Arl6 is the gene underlying BBS type 3 [23]. Analysis of BBS
morphants in zebrafish showed that aberrant neural crest
migration underlies the craniofacial and enteric nervous system
defects mirroring mammalian mutants [24], suggesting that BBS-
associated genes might be involved in NC migration. In our
studies, arl6ip1 morphants exhibit similar defective phenotypes,
such as craniofacial dysmorphology and inhibition of trunk NC
migration. We also found the loss of enteric neurons in arl6ip1
morphants. Therefore, we concluded that Arl6ip1 might function
in NC cell development through interaction with Arl6. In
addition, by loss-of-function studies, our results showed that
knockdown of arl6ip1 negatively affects NC development,
indicating, in turn, that arl6ip1 could be an underlying etiological
factor in the onset of BBS and other neurocristopathies.
Materials and Methods
Fish husbandry and observation
The wild-type AB strain of zebrafish was cultured at 28.5uC.
Embryos were staged by hpf [51]. The phenotype of heart
formation was observed under a fluorescent stereomicroscope, MZ
FLIII (Leica). Images were captured with a Fine pix S2 pro camera
(Nikon) using the Camera Shooting software.
MO knockdown
The MOs were specifically designed to inhibit the translation of
arl6ip1 mRNA as follows: fluorescence-tagged arl6ip1-MO1 and
arl6ip1-MO1, 59-ACTTTTATTGT- CGCCCTCAGCCATG-39,
and arl6ip1-MO2, 59-GATGTTACTTGAGAGTTTAGG-
TTCC-39. A control MO specific for Arl6ip1 was designed as 59-
GTACCGACT- CCCGCTGTTATTTTCA-39, which is an
inverted sequence of arl6ip1-MO1. We also designed p53-MO,
59-GCGCCATTGCTTTGCAAGAATTG-39, to suppress the
cell death induced by MO off-targeting. The amount of p53-
MO injected was 1.5-fold (w/w) higher than the amount of MO
previously described [26]. All MOs were prepared at a stock
concentration of 1 mM and diluted to the desired concentration
for microinjection into each embryo.
Whole-mount in situ hybridization and TUNEL assay
Digoxigenin (DIG)-labeled antisense RNA probe used for
whole-mount in situ hybridization was generated by using DIG
RNA labeling kit (Roche). Embryos at the desired stage were
collected and then fixed with 4% paraformaldehyde for 4 h at
25uC. After fixation, embryos were dechrionized, dehydrated in
absolute alcohol, and stored at 220uC. Embryos were rehydrated
by immersion for 10 min each in 75%, 50%, and 25% ethanol.
Rehydrated embryos were transferred to phosphate buffer saline
(PBS). Prehybridization, hybridization, and detection procedures
were performed with a DIG detection kit II, according to the
instructions in the supplier’s manual (Boehriner Mannheim). The
TUNEL assay was described previously [52] using The Dead-
End
TM Colorimetric TUNEL System (Promega) or DeadEnd
TM
Fluorometric TUNEL System. The overlapping signals of crestin-
and fluorescent TUNEL-positive cells were detected and counted
under a fluorescent stereomicroscope, MZ FLIII (Leica).
Plasmid construction
In order to further demonstrate the specificity of MO targeting,
we constructed plasmids of pCS2-Arl6ip1-GFP, in which the
binding sequence of arl6ip1-MO1 was fused with the GFP reporter
cDNA. The NotI-cut pCS2-Arl6ip1-GFP served as a template to
synthesize RNA using the mMessage Machine kit (Ambion). The
resultant arl6ip1-MO1-target-gfp RNA was injected at 100 pg per
embryo or co-injected with 4 ng arl6ip1-MO1 into one-celled
zebrafish embryos. Appearance of the GFP signal in the treated
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microscopy.
Rescue experiment
Since the introduced arl6ip1 mRNA was not bound by arl6ip1-MO1
during the rescue experiment, we designed a wobble arl6ip1 and
arl6ip1-gfp mRNA. The wobble arl6ip1-gfp mRNA was a wobble arl6ip1
cDNA fused in frame with egfp cDNA, and we changed the nt 125–149
of zebrafish arl6ip1 cDNA (GenBank Accession NO. NM_201112)
from 59-ATGGCTGAGGGCGACAATAAAAGTG-39 to 59-
ATGGCcGAaGGaGAtAAcAAgAGcG-39,b u tw i t h o u ta l t e r i n gt h e
amino acid residues. Capped mRNA transcripts of wobble arl6ip1 and
wobble arl6ip1-gfp for rescue experiments were synthesized by SP6 in
vitro transcription, according to the protocol of the manufacturer
(Epicentre). The resultant mRNAs were diluted to the desired
concentration (from 100 to 300 pg/ml), and approximately 2.3 nl
were microinjected into one-celled stage embryos.
Whole-mount immunofluorescence staining
Anti-Hu antibodies were used to detect cranial ganglia, enteric
neurons, and dorsal root ganglia, as described by O’Brien et al.
(2004) [53]. After embryos were fixed in 0.4% paraformaldehyde
at pH 7.2 for 4 hr at room temperature, they were washed three
times with PBS for 15 min each, soaked in 100% acetone at
220uC for at least 10 min, rehydrated through graded methanol
in PBS and placed in blocking solution at room temperature for
1 hr (5% sheep serum, 1% bovine serum albumin (BSA), 1%
dimethylsulfoxide and 0.1% Tween 20 in PBS). After blocking, the
embryos were subjected to primary antibody at 4uC overnight.
The embryos were then extensively washed with 1% BSA in PBST
and incubated at 4uC overnight with gentle mixing in goat anti-
mouse immunoglobulin conjugated with Cy3, 2 mg/ml diluted
1:50 in blocking solution. The embryos were washed extensively in
1% BSA in PBST and finally in PBS.
Cartilage staining
The Alcian blue staining protocol followed Neuhauss et al.
(1996) [54] with some modifications. Embryos at 4 dpf were
anesthetized using 0.02% buffered tricaine (Sigma) and fixed
overnight in 4% PFA at 4uC. After washing with PBS, embryos
were stained overnight in 0.1% Alcian blue, which was dissolved in
acidic ethanol (70% ethanol, 5% concentrated hydrochloric acid),
then washed extensively in acidic ethanol, dehydrated, and stored
in 80% glycerol. For better exposure of cartilage elements,
embryos were digested with 0.02% trypsin.
Supporting Information
Figure S1 Confirmation of specific activities of arl6ip1-
MO1 in zebrafish embryos. (A) Injection of 4 ng arl6ip1-MO1
caused brain lesions and foreshortened trunks. The defects of
arl6ip1-MO1 were rescued either partially by the wobble arl6ip1
mRNA (E) and wobble arl6ip1-gfp mRNA (B) or almost completely
by wobble arl6ip1-gfp mRNA with p-53 MO (C). (F, G) By
detecting the GFP signals, we confirmed that the arl6ip1-MO1
cannot target wobble arl6ip1-gfp mRNA. (D) The Arl6ip1-GFP
fusion protein was detected at 24 hpf in embryos injected with
arl6ip1-MO1-target-gfp mRNA. (H) The GFP signal was absent at
24 hpf in embryos co-injected with arl6ip1-MO1-target-gfp mRNA
and arl6ip1-MO1. (I) The arl6ip1 morphants did not display sulcus
and gyrus in brains, and these brain defects were rescued either
partially by wobble arl6ip1-gfp mRNA (J) or completely by wobble
arl6ip1-gfp mRNA with p53-MO (K).
(TIF)
Figure S2 The arl6ip1-MO1-injected embryos do not
appear to have defective patterning in hindbrain. Wild-
type (WT; A, C, E) and arl6ip1-knockdown (MO; B, D, F)
embryos, either at 3-somite stage (3ss) (A–D) or at 24 hpf (E, F),
were observed at dorsal view. (A–D) Neither fgf3 expression nor
fgf8 expression in the arl6ip1 morphants was distinguishable from
that of wild-type embryos (A vs. B; C vs. D). (E, F) Dorsal views of
24 hpf embryos processed for anti-Hu immunofluorescence
staining (IFA) to reveal hindbrain segmentation. Similar to WT
embryos, arl6ip1-knockdown embryos showed normal r1-r7
segmentation. fb, forebrain; mhb, midbrain-hindbrain border;
pr4, premature rhombomere 4; r1–r7, rhombomere 1–7.
(TIF)
Figure S3 Induction of neural crest cells occurs nor-
mally in arl6ip1-MO1 embryos. (A, B) Dorsal views of
embryos at 10 hpf processed to show sox2 expression (labeling
neural plate: np), and dlx3b expression (labeling the pre-placodal
region: ppr). (A9,B 9) Higher magnification views of right side of
embryos shown in panels A and B, respectively. The region
between these two expression domains was normally occupied by
pre-migratory neural crest cells (indicated by brackets in A9 and
B9).
(TIF)
Figure S4 Injection of 75 pg wobble arl6ip1 mRNA
enables embryos to rescue the defects induced by 4 ng
arl6ip1-MO1. (A–C) Dorsal views of 3-somite-stage embryos,
anterior to the top. (D–F) Lateral views of 24 hpf embryos,
anterior to the left. (A, B) Compared to wild-type embryos,
decreased expression of foxd3 was evident and predominant,
especially in caudal region of pre-migratory neural crest cells in
arl6ip1 morphants. (C) The down-regulation of foxd3 in arl6ip1-
MO1 embryos was rescued by the wobble arl6ip1 mRNA. (D, E)
Crestin-positive neural crest cells that normally migrate ventrally
from the neural tube into the trunk were disrupted in arl6ip1
morphants (indicated by arrows). (F) Co-injection of wobble arl6ip1
mRNA with arl6ip1-MO1 recovered neural crest migration. (G)
Quantification of the number of streams of sox10-labeled neural
crest cells certified that migratory defects in arl6ip1 morphants can
be rescued by wobble arl6ip1 mRNA.
(TIF)
Figure S5 Abnormal Sonic Hedgehog signaling in arl6ip1-
MO1/p53-MO morphants. (A–D) Lateral views of 24hpf
embryos, anterior to the left. (A, B) Expression of shh was normal,
either in wild-type embryos (A) or arl6ip1-MO1/p53-MO-injected
embryos (B). (C, D) pax6, a gene negatively regulated by Shh
signaling, was up-regulated in the neural tube of arl6ip1-MO1/
p53-MO-injected embryos (D). Neural tube: indicated by arrow.
(TIF)
Figure S6 Knockdown of Arl6ip1 induces KV cilia defects. (A–
D) pitx2 normal expression in left lateral plate mesoderm
(LPM)(arrow) at 20-somite stage was disrupted in embryos injected
with arl6ip1-MO1/p53-MO. (E–H) At 20-somite stage, spaw is
expressed in the left LPM (arrow), while knockdown of Arl6ip1/
P53 resulted in left (E), absent (F), bilateral (G) or rightward (H)
spaw expression in the LPM. (I, J) Confocal microscopic images of
anti-acetylated tubulin staining of KV cilia (red fluorescent) at 8-
somite stage. In the wild-type embryos, cilia can be observed in a
spherical pattern in the region of KV (I). Cilia number, length and
KV area reduced in arl6ip1-MO1/p53-MO morphants at 8-somite
stage (J). (K) Summary of pitx2 and spaw asymmetrical gene
expression patterns.
(TIF)
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development without other effects on embryogenesis. (A) As
observed under fluorescent microscopy, injection of fluorescein-
tagged arl6ip1-MO1 into mid-blastula stage embryos was observed
in dorsal forerunner cells (DFCs) 3–4 hr post-injection at 70%
epiboly stage. The dorsal margin was indicated by dashed line. (B–
E) Lateral views of 24hpf embryos. Embryos were observed under
transmitted light microscopy (B, C) or fluorescent microscopy (D,
E). MOs were present in all cells of embryos injected at the one-
cell stage (D), and severe defects induced by fluorescein-tagged
arl6ip1-MO1 embryos were shown (B). Fluorescein-tagged arl6ip1-
MO1 injected into embryos at mid-blastula stage was primarily
found in the yolk cell and yolk tube (E), indicating that cells, other
than DFC and yolk, did not incorporate MO. These DFC of
arl6ip1-MO1-injected embryos (DFC
arl6ip1-MO1) developed a nor-
mal morphology (C) similar to WT embryos. (F, G) Tail views of 6-
somite stage embryos. KV was indicated by arrows. Compared to
WT embryos (F), DFC
arl6ip1-MO1 embryos showed reduced KV at
6-somite stage (G). (H, I) Confocal microscopy images of anti-
acetylated tubulin staining of KV cilia (red fluorescent) at 6-somite
stage. Cilia distributed over a spherical pattern in the region of KV
(H). However, cilia were disorganized in reduced KV of
DFC
arl6ip1-MO1 embryos (I). (K) Summary of pitx2 and spaw
asymmetrical gene expression patterns.
(TIF)
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